Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marlies C van der Goes

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|January 12, 2023
[Low dosed prednisolone in older patients with rheumatoid arthritis]Marlies C van der Goes
Arthritis Research & Therapy|January 23, 2015
The value of glucocorticoid co-therapy in different rheumatic diseases--positive and adverse effectsMarlies C van der Goes, Johannes W Jacobs, Johannes W Bijlsma
Current Opinion in Rheumatology|March 11, 2016
Rediscovering the therapeutic use of glucocorticoids in rheumatoid arthritisMarlies C van der Goes, Johannes W G Jacobs, Johannes W J Bijlsma
Clinical and Experimental Rheumatology|August 6, 2013
Glucocorticoids in systemic sclerosis: weighing the benefits and risks - a systematic reviewMichele Iudici, Marlies C van der Goes, Gabriele Valentini, et al.
Journal of Medical Cases|August 26, 2021
Palmar Fasciitis and Polyarthritis Syndrome: A Rare Paraneoplastic Syndrome in a Patient With Prostate CarcinomaAnouk G de Boer, Ruth Klaasen, Marlies C van der Goes, et al.
Best Practice & Research. Clinical Rheumatology|January 24, 2012
GlucocorticoidsCornelia M Spies, Cindy Strehl, Marlies C van der Goes, et al.
Expert Opinion on Investigational Drugs|January 4, 2017
Glucocorticoid-targeted therapies for the treatment of rheumatoid arthritisCindy Strehl, Marlies C van der Goes, Johannes W J Bijlsma, et al.
Annals of the New York Academy of Sciences|April 20, 2010
Low-dose glucocorticoid therapy in rheumatoid arthritis: an obligatory therapyJohannes W J Bijlsma, Marlies C van der Goes, Jos N Hoes, et al.
Frontiers in Immunology|March 16, 2019
Heat Shock Proteins Can Be Surrogate Autoantigens for Induction of Antigen Specific Therapeutic Tolerance in Rheumatoid ArthritisWillem van Eden, Manon A A Jansen, Irene S Ludwig, et al.
Rheumatology (Oxford, England)|August 20, 2011
Changes in macrophage inhibitory factor correlate with changes in bone mineral density in glucocorticoid-treated patients with rheumatoid arthritisJos N Hoes, Marlies C Van der Goes, Johannes W G Jacobs, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Nederlands Tijdschrift Voor Geneeskunde|January 12, 2023
[Low dosed prednisolone in older patients with rheumatoid arthritis]Marlies C van der Goes
Arthritis Research & Therapy|January 23, 2015
The value of glucocorticoid co-therapy in different rheumatic diseases--positive and adverse effectsMarlies C van der Goes, Johannes W Jacobs, Johannes W Bijlsma
Current Opinion in Rheumatology|March 11, 2016
Rediscovering the therapeutic use of glucocorticoids in rheumatoid arthritisMarlies C van der Goes, Johannes W G Jacobs, Johannes W J Bijlsma
Clinical and Experimental Rheumatology|August 6, 2013
Glucocorticoids in systemic sclerosis: weighing the benefits and risks - a systematic reviewMichele Iudici, Marlies C van der Goes, Gabriele Valentini, et al.
Journal of Medical Cases|August 26, 2021
Palmar Fasciitis and Polyarthritis Syndrome: A Rare Paraneoplastic Syndrome in a Patient With Prostate CarcinomaAnouk G de Boer, Ruth Klaasen, Marlies C van der Goes, et al.
Best Practice & Research. Clinical Rheumatology|January 24, 2012
GlucocorticoidsCornelia M Spies, Cindy Strehl, Marlies C van der Goes, et al.
Expert Opinion on Investigational Drugs|January 4, 2017
Glucocorticoid-targeted therapies for the treatment of rheumatoid arthritisCindy Strehl, Marlies C van der Goes, Johannes W J Bijlsma, et al.
Annals of the New York Academy of Sciences|April 20, 2010
Low-dose glucocorticoid therapy in rheumatoid arthritis: an obligatory therapyJohannes W J Bijlsma, Marlies C van der Goes, Jos N Hoes, et al.
Frontiers in Immunology|March 16, 2019
Heat Shock Proteins Can Be Surrogate Autoantigens for Induction of Antigen Specific Therapeutic Tolerance in Rheumatoid ArthritisWillem van Eden, Manon A A Jansen, Irene S Ludwig, et al.
Rheumatology (Oxford, England)|August 20, 2011
Changes in macrophage inhibitory factor correlate with changes in bone mineral density in glucocorticoid-treated patients with rheumatoid arthritisJos N Hoes, Marlies C Van der Goes, Johannes W G Jacobs, et al.
Pageof 3